Milestone Pharmaceuticals Inc. (MIST) Tops Q2 EPS by 5c

Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported Q2 EPS of ($0.14), $0.05 better than the analyst estimate of ($0.19).

For earnings history and earnings-related data on Milestone Pharmaceuticals Inc. (MIST) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
• Beam Global (BEEM) Tops Q2 EPS by 8c